Tuesday, Adaptive Biotechnologies Corporation (ADPT) announced financial results for the first quarter, revealing a net loss attributable to the company of $20.03 million, or $0.13 a share, compared to $29.6 million, or $0.20 a share, in the prior year.
Loss from operations amounted to $19.2 million compared to $29.6 million in the previous year.
Revenue increased to $70.9 million from $52.4 million last year.
In the after hours, ADPT is trading at $16.80, up 21.92 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.